GLPwatch
Time to approve glucagon-like peptide-1 receptor agonists for MASLD: a rational step based on robust evidence.
Diabetologia · 2025
Last updated 2026-07-19| Journal | Diabetologia, 2025 |
|---|---|
| Citations | 3 |
| Molecules | — |
| Conditions studied | Mash |
Full record and abstract on PubMed 40866732 ↗